Integration of (iSBIRT) for Teen Drug Use Into a Pediatric Network

October 6, 2016 updated by: John R Knight, MD, Boston Children's Hospital

Integration of Internet-facilitated Screening, Brief Intervention, Referral to Treatment (iSBIRT) for Teen Drug Use Into a Pediatric Network

The Goal of this project is to integrate a previously-tested internet-facilitated Screening, Brief Intervention, and Referral to Treatment (iSBIRT) system for adolescent substance use into a large network of primary care offices, the Pediatric Practices of Children's Hospital Boston (PPOC).

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Study Type

Interventional

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Children's Hospital Boston

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 12-18 year olds
  • Coming for non-emergent care
  • Access to a private computer
  • Have email address

Exclusion Criteria:

  • Not available for follow-up questionnaires
  • Unable to read or understand English at a 6th grade reading level
  • Medically or emotionally unstable on the day of the visit

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Treatment as Usual
Experimental: iSBIRT
Participants will receive the internet-facilitated screening, brief intervention and referral to treatment (iSBIRT intervention)
Behavioral: iSBIRT
Participants will be screened for substance use, view information about the health effects of substance use on the computer, and receive advice from the primary care provider regarding the health effects of substance use. Those found to be at "high risk" will complete an internet-based program encouraging them to change their substance use.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Provider attitude toward iSBIRT
Time Frame: 12 months post baseline
We will evaluate providers' acceptance of and attitude toward integrating iSBIRT into their practices.
12 months post baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Youth connectedness to provider
Time Frame: Baseline
We will measure adolescents' attitudes toward their providers' advice regarding the health effects of substance use given during the visit
Baseline
iSBIRT sustainability
Time Frame: 12 months post
We will measure rates of continued use of iSBIRT by practices 12 months after iSBIRT recruitment and implementation ends
12 months post
Change in rates of adolescent substance use
Time Frame: 3 months post baseline
We will measure the change in rates of adolescent substance use from baseline to 3 months post study visit.
3 months post baseline
Change in rates of adolescent substance use
Time Frame: 6 months post baseline
We will measure the change in rates of adolescent substance use from baseline to 6 months post study visit.
6 months post baseline
Change in rates of adolescent substance use
Time Frame: 12 months post baseline
We will measure the change in rates of adolescent substance use from baseline to 12 months post study visit.
12 months post baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Boston Children's Hospital

Investigators

  • Principal Investigator: John R Knight, MD, Boston Children's Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2012

Primary Completion (Anticipated)

October 1, 2016

Study Completion (Anticipated)

December 1, 2016

Study Registration Dates

First Submitted

October 5, 2011

First Submitted That Met QC Criteria

October 14, 2011

First Posted (Estimate)

October 18, 2011

Study Record Updates

Last Update Posted (Estimate)

October 7, 2016

Last Update Submitted That Met QC Criteria

October 6, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CeASAR app RFADA12008

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance Use

Clinical Trials on iSBIRT

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe